abstract |
A compound of Formula I: ** (See formula) ** or a pharmaceutically acceptable salt thereof, in combination with an anti-PD-1 antibody for use in the treatment of a cancer; wherein R1 is NH2 or CH3; R2 is Cl, Br, CF3, CH3 or CN; R3 is H or F; and n is 1 or 2. |